Clinical Trials Browser

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Acute

NCT03453255 2018-03-05

DCHA as Postremission Therapy for AML With t(8;21)

Phase 1/2 Unknown

120 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00145626 2017-06-19

HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies

Phase 2 Completed

40 enrolled 18 charts

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00640796 2014-04-24

Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors

Phase 1 Completed

22 enrolled

LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00428558 2013-12-20

Timed-Sequential Induction in CBF-AML

Phase 3 Completed

200 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00390715 2010-03-15

Treatment of Acute Myeloblastic Leukemia in Younger Patients

Completed

600 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00931138 2009-07-02

ALFA 9801

Phase 3 Completed

420 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00152139 2009-01-29

Stem Cell Transplantation for Patients With Hematologic Malignancies

Phase 3 Completed

33 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hemoglobinuria, Paroxysmal, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Clinical Trials

The Efficacy of Allo-HSCT in ND HR-CBF-AML

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia

Repurposing Itraconazole as an Adjuvant Therapy in Treatment of Patients With Acute Myeloid Leukemia: Is it a Hopeful Avenue for Enhancing Treatment Options?

Risk Stratification-directed Therapy for AML With t(8;21) /AML1-ETO+

Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT

Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations

HINKL

Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay

DCHA as Postremission Therapy for AML With t(8;21)

HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies

Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors

Timed-Sequential Induction in CBF-AML

Treatment of Acute Myeloblastic Leukemia in Younger Patients

ALFA 9801

Stem Cell Transplantation for Patients With Hematologic Malignancies